Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST

BACKGROUND: In the Beta-Blocker Evaluation of Survival Trial (BEST) trial, systolic blood pressure (SBP) ≤120 mm Hg was an independent predictor of poor prognosis in ambulatory patients with chronic systolic heart failure (HF). Because SBP is an important predictor of response to beta-blocker therap...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: White, Michel, Desai, Ravi V., Guichard, Jason L., Mujib, Marjan, Aban, Inmaculada B., Ahmed, Mustafa I., Feller, Margaret A., de Denus, Simon, Ahmed, Ali
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769783/
https://ncbi.nlm.nih.gov/pubmed/21982425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjca.2011.07.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki